human monoclonal antibody discovery

IDBiologics was founded to discover and develop human monoclonal antibodies (mAbs) for the prevention and treatment of infectious diseases. Founded from the laboratory of Professor James Crowe at Vanderbilt University Medical Center (VUMC), its fully human mAb platform enables rapid discovery and optimization of broad and potent therapeutic mAbs with neutralizing activity to a range of viral targets. The company is based in Nashville, Tennessee.

Read more

antibody optimizationtherapeutic antibody development